ATE554782T1 - Synergistische formulierung auf eukaryotischer basis gegen gastrointestinale erkrankungen - Google Patents

Synergistische formulierung auf eukaryotischer basis gegen gastrointestinale erkrankungen

Info

Publication number: ATE554782T1
Authority: AT; Austria
Prior art keywords: formulation; medium; eukaryotic; eukaryolics; gastro
Prior art date: 2004-08-23

Application number

AT04770696T

Other languages

English (en)

Inventor

Krishna Ella

Srinivas Vellimedu

Sivasankara Sunkara

Original Assignee

Bharat Biotech Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-23

Filing date

2004-08-23

Publication date

2012-05-15

2004-08-23 Application filed by Bharat Biotech Int Ltd filed Critical Bharat Biotech Int Ltd

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE554782T1 publication Critical patent/ATE554782T1/de

Links

238000009472 formulation Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
208000018522 Gastrointestinal disease Diseases 0.000 title abstract 3
230000002195 synergetic effect Effects 0.000 title abstract 2
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
235000000638 D-biotin Nutrition 0.000 abstract 1
239000011665 D-biotin Substances 0.000 abstract 1
235000010469 Glycine max Nutrition 0.000 abstract 1
244000068988 Glycine max Species 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
239000004327 boric acid Substances 0.000 abstract 1
235000010338 boric acid Nutrition 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
239000005018 casein Substances 0.000 abstract 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
235000021240 caseins Nutrition 0.000 abstract 1
239000008121 dextrose Substances 0.000 abstract 1
235000013399 edible fruits Nutrition 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 abstract 1
229910000359 iron(II) sulfate Inorganic materials 0.000 abstract 1
SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 abstract 1
229910000357 manganese(II) sulfate Inorganic materials 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
229960003495 thiamine Drugs 0.000 abstract 1
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
229940088594 vitamin Drugs 0.000 abstract 1
239000011782 vitamin Substances 0.000 abstract 1
229930003231 vitamin Natural products 0.000 abstract 1
235000013343 vitamin Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Natural Medicines & Medicinal Plants (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)

AT04770696T 2004-08-23 2004-08-23 Synergistische formulierung auf eukaryotischer basis gegen gastrointestinale erkrankungen ATE554782T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2004/000256 WO2006021965A1 (en)	2004-08-23	2004-08-23	Eukaryotic based synergistic formulation for gastro-intestinal disorders

Publications (1)

Publication Number	Publication Date
ATE554782T1 true ATE554782T1 (de)	2012-05-15

Family

ID=34958645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04770696T ATE554782T1 (de)	2004-08-23	2004-08-23	Synergistische formulierung auf eukaryotischer basis gegen gastrointestinale erkrankungen

Country Status (4)

Country	Link
US (1)	US20080226614A1 (de)
EP (1)	EP1796700B1 (de)
AT (1)	ATE554782T1 (de)
WO (1)	WO2006021965A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8476058B2 (en) *	2007-12-26	2013-07-02	Lesaffre Et Compagnie	Probiotic yeast compositions and methods for inflammatory diseases
IT1405757B1 (it) *	2010-11-03	2014-01-24	Gruppo Farmaimpresa Srl	Preparazione farmaceutica comprendente saccaromyces e simeticone per il trattamento delle patologie gastrointestinali
GB201807046D0 (en) *	2018-04-30	2018-06-13	Helperby Therapeutics Ltd	Combination
FR3120789B1 (fr)	2021-03-16	2024-01-19	Lesaffre & Cie	Inhibiteurs glycosidiques de levure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB930107A (en) *	1960-01-11	1963-07-03	Giuseppe Carlo Sigurta	Therapeutic oral preparation of micro-organisms
US4595590A (en) *	1984-01-17	1986-06-17	Laboratoires Biocodex	Method for preventing or treating pseudo-membranous colitis
US4806368A (en)	1987-09-16	1989-02-21	Reddy Malireddy S	Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US5501857A (en) *	1992-07-24	1996-03-26	Midwestern Bio-Ag Products & Services, Inc.	Oral nutritional and dietary composition
DE69530419D1 (de) *	1994-07-29	2003-05-22	Us Agriculture	Saccharomyces-behandlung zur verringerung von campylobakter- und salmonella-populationen in geflügel
NZ291659A (en) *	1994-09-06	2001-04-27	Galagen Inc	Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile
US5722342A (en) *	1996-06-28	1998-03-03	Us Agriculure	Ovo antibiotic and microbial treatment to dimenish salmonellae populations in avians
IN183097B (de) *	1997-03-27	1999-09-04	Rajiv Indravadan Dr Modi
US6426099B1 (en)	1997-12-03	2002-07-30	Renew Life, Inc.	Herbal formulation for rebuilding intestinal bacteria
US6461607B1 (en) *	1998-08-24	2002-10-08	Ganeden Biotech, Inc.	Probiotic, lactic acid-producing bacteria and uses thereof
NL1010770C2 (nl) *	1998-12-09	2000-06-13	Nutricia Nv	Preparaat dat oligosacchariden en probiotica bevat.
US6468525B1 (en) *	1999-08-10	2002-10-22	Renew Life, Inc.	Probiotic formulation
US6878373B2 (en) *	2001-12-03	2005-04-12	Micropure Technologies, Inc.	Probiotic composition containing Bacillus cereus RRRL B-30535

2004
- 2004-08-23 AT AT04770696T patent/ATE554782T1/de active
- 2004-08-23 US US11/660,976 patent/US20080226614A1/en not_active Abandoned
- 2004-08-23 EP EP04770696A patent/EP1796700B1/de not_active Expired - Lifetime
- 2004-08-23 WO PCT/IN2004/000256 patent/WO2006021965A1/en not_active Ceased

Also Published As

Publication number	Publication date
US20080226614A1 (en)	2008-09-18
EP1796700A1 (de)	2007-06-20
EP1796700B1 (de)	2012-04-25
WO2006021965A1 (en)	2006-03-02

Similar Documents

Publication	Publication Date	Title
AR109170A2 (es)	2018-11-07	Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente
CY1118517T1 (el)	2017-07-12	Πνευμονικη χορηγηση για λεβοντοπα
ECSP055774A (es)	2005-11-22	Nuevo medicamento para el tratamiento de la enfermedad pulmonar obstructiva crónica
WO2005019163A3 (en)	2005-04-28	Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
NO2013017I2 (no)	2015-09-07	(a)dekstrometorfan eller et farmasøytisk akseptabelt salt derav, for eksempel dekstrometorfanhydrobromid og (b) quinidin eller etfarmasøytisk akseptabelt salt derav, for eksempel quinidinsulfat
DK2023918T3 (da)	2011-04-26	Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
UY27755A1 (es)	2003-11-28	Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
ECSP045208A (es)	2004-09-28	Aza-arilpiperazinas
CY1115484T1 (el)	2017-01-04	Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
WO2008021088A3 (en)	2008-12-24	Salicylanilides enhance oral delivery of therapeutic peptides
WO2007044085A3 (en)	2007-06-28	Heteroaryl compounds and their uses as therapeutic agents
EP2510811A3 (de)	2018-01-03	Verwendung von Nährstoffzusammensetzungen zur Vorbeugung von Erkrankungen
FI3457135T3 (fi)	2025-03-08	Fabryn taudin hoitovaihtoehtoja
WO2008052044A3 (en)	2009-07-30	Use of derivatives of propofol for treating diseases associated with oxidative stress
CY1118179T1 (el)	2017-06-28	Φαρμακευτικη συνθεση
ATE538666T1 (de)	2012-01-15	Nahrungsergänzung zur verhinderung von abmagerungen
AR062659A1 (es)	2008-11-26	Composicion de liberacion sostenida de levodopa y metodo para su uso
MX2008004734A (es)	2008-10-23	Composicion rica en leucina.
WO2006138608A3 (en)	2007-04-26	Pharmaceutical compositions and use thereof
WO2007046867A3 (en)	2007-07-05	Piperidine derivatives and their uses as therapeutic agents
WO2008032222A3 (en)	2008-05-02	Treatment of vertigo with acetyl-l-leucine
WO2007133796A3 (en)	2008-02-07	Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
EA200500764A1 (ru)	2005-12-29	Фармацевтические композиции и лекарственные формы для трансбуккальной и сублингвальной доставки тизанидина и способы введения тизанидина сублингвально или трансбуккально
WO2008023003A8 (de)	2008-05-22	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UA86399C2 (ru)	2009-04-27	Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза